Encompass Health Cuts 2026 Provider-Tax Boost To About $3 Million From $10 Million As Florida Approval Hangs

The rehab hospital operator reversed Florida accruals, and approval in the fourth quarter could add about $8 million to EBITDA.

Share
Encompass Health Cuts 2026 Provider-Tax Boost To About $3 Million From $10 Million As Florida Approval Hangs

Encompass Health, which runs inpatient rehabilitation hospitals, now expects net provider taxes to add only about $3 million to 2026 adjusted EBITDA, down from the roughly $10 million it projected last quarter, CFO Doug Coltharp said on the company's third-quarter earnings call Thursday. The cut follows reversals tied to a Florida Medicaid payment program that federal regulators have not yet approved.

Florida accruals reversed

Coltharp said the company reversed $9.2 million of previously accrued supplemental payments, booked in other revenue, tied to the anticipated approval of Florida's fiscal 2026 Medicaid state directed payment program. It also reversed $3.4 million of accrued provider tax expense in other operating expenses. The program is still pending at CMS, the federal Medicare and Medicaid agency, and Florida's fiscal year ended September 30, so he said management judged the adjustment appropriate.

In the second quarter, the company had cut its provider-tax estimate to about $10 million, based mainly on CMS approval in May 2026 of Florida's fiscal 2025 program. For the first nine months, net provider taxes added $600,000 to adjusted EBITDA, against $18.1 million a year earlier.

Third-quarter adjusted EBITDA still rose 15.5% to $346.6 million, even with an $11.5 million year-over-year drop in net provider tax contributions. Management raised its 2026 guidance again, to adjusted EBITDA of $1.395 billion to $1.415 billion.

An $8 million swing if CMS says yes

Asked by an analyst from UBS about a possible Florida waiver, Coltharp said CMS had issued no decision, positive or negative, on the state's proposal, which would include waivers for many of the company's hospitals there. Approval in the fourth quarter could lift EBITDA by about $8 million, he said: the roughly $5.5 million net impact reversed this quarter plus the fourth-quarter pickup.

For 2027, he said the company will not have to repeat these accrual adjustments, which "should present some some upside." He added that approval of the waivers as submitted would also help, and that the company does not expect to repeat the $11.5 million hit it took in the second quarter on the fiscal 2025 Florida plan.

Business behind the quarter

Encompass Health operated 173 hospitals in 39 states and Puerto Rico at the end of 2025, according to its annual report, and is paid mainly by Medicare and Medicare Advantage. CEO Mark Tarr said third-quarter revenue grew 8.9% and adjusted earnings per share rose 23.6%.

Bad debt expense was 2.7% of revenue, which Coltharp blamed mainly on a billing disruption after a system conversion in the second quarter. He expects it to return to 2% to 2.5% in the fourth quarter. Net leverage ended the quarter at 1.8 times.

The next marker is CMS: a fourth-quarter decision on Florida's fiscal 2026 program is what Coltharp said could add about $8 million to EBITDA.

Sources

More on Encompass Health

All Encompass Health (EHC) coverage →